ClinicalTrials.gg
CompletedNCT03350880FlexibilityUpdated Jul 29, 2022

Stretching Isquiotibials in Water and on Land in Healthy Adutls

An interventional study of Flexibility training in Muscle Relaxation, sponsored by Universidade Federal do vale do São Francisco. Completed at 1 site in Brazil. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-29.

Sponsored by Universidade Federal do vale do São Francisco · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Comparison of therapeutic intervention to gain range of motion at the hip joint within therapeutic in water and on land. Stretching is a therapeutic maneuver used to increase the length of shortened soft tissue structures and thereby gain range of motion; for that, innumerable procedures within Physiotherapy use it for the benefit of patients. The work in question is justified by the need to seek the means that can promote a better performance in the application of the stretching procedure, called Proprioceptive Neuromuscular Facilitation, in a universe of pre-selected volunteers. It is a relevant and feasible study, hoping that its results may benefit future patients, with better results and faster responses. What is the medium that leads to better results in a program using the proprioceptive neuromuscular facilitation technique? Hypotheses: a - Probably the heated aquatic environment, in a range of 32 ° to 36 ° C, will promote a better result, since the heat increases the collagen's distensibility. b - Perhaps the heat, by increasing the excitability threshold of nerve fibers, triggers the "protective reflex" later, which may promote a more vigorous elongation without the protective response. c - Possibly the relaxation promoted in the aquatic environment, could influence the gains obtained in the swimming pool.

Read the detailed description

Comparison of therapeutic intervention to gain range of motion at the hip joint within therapeutic in water and on land.

02

Conditions studied

  • Muscle Relaxation

Keywords

  • Passive
  • Stretching
  • Water
  • Proprioceptive Neuromuscular Facilitation (PNF)
03

In context

Lead sponsor

Universidade Federal do vale do São Francisco is the lead sponsor of 14 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 18 and 60 years;
  • sedentary and who did not perform physiotherapy and physical activity in the last three months;
  • clinical and cognitive conditions for swimming pool activities and aerobic exercise; who have not undergone highly complex surgical procedures in the last six months;
  • to be able of walking without help equipment and without musculoskeletal or skeletal diseases;
  • without to the practice of exercises; such as: urinary and / or fecal incontinence and dermatological diseases;
  • below obesity II with \<40.

Exclusion criteria

Exclusion Criteria:

  • if they have up to three consecutive fouls during the hydrogymnastics period;
  • if they present any adverse effects, such as: allergy or any dermatitis;
  • unable to continue the study due to change of address or hospitalization.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    PNF in Water - PNFW

    Flexibility training was carried out over a period of six weeks, with two sessions per week, totaling 12 sessions.

    Other: Flexibility training

  • Active comparator
    PNF on Land - PNFL

    Flexibility training was carried out over a period of six weeks, with two sessions per week, totaling 12 sessions.

    Other: Flexibility training

Interventions

  • OtherFlexibility training

    Flexibility training was carried out over a period of six weeks, with two sessions per week, totaling 12 sessions.

    Also known as: streching training

06

What researchers measure

Primary outcomes

  1. range of motion

    range of motion by goniometer

    Time frame: six weeks

Secondary outcomes

  1. sit and reach test

    sit and reach test by wells bank

    Time frame: six weeks

07

Study locations

1 site
  • Physical Education College
    Petrolina, Pernambuco 56304917, Brazil
08

References and documents

Publications

  • Ribeiro, Hálisson Alves, et al.

Individual participant data

Plan to share: Yes — Papers and abstract congress

Supporting information: Clinical study report

Time frame: one year

Access criteria: age between 18 and 60 years; sedentary and who did not perform physiotherapy and physical activity in the last three months; clinical and cognitive conditions for swimming pool activities and aerobic exercise; who have not undergone highly complex surgical procedures in the last six months; to be able of walking without help equipment and without musculoskeletal or skeletal diseases; without contraindications to the practice of exercises; such as: urinary and / or fecal incontinence and dermatological diseases; below obesity II with BMI \<40.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03350880
Lead sponsor
Universidade Federal do vale do São Francisco
Responsible party
Rodrigo Gustavo da Silva Carvalho (Master, Universidade Federal do vale do São Francisco) — Principal investigator
First posted
Nov 22, 2017
Start date
Jan 1, 2018
Primary completion
Aug 28, 2018
Completion
Nov 1, 2018
Last update
Jul 29, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion